325 related articles for article (PubMed ID: 27806619)
1. Use of novel thermobrachytherapy seeds for realistic prostate seed implant treatments.
Warrell G; Shvydka D; Parsai EI
Med Phys; 2016 Nov; 43(11):6033. PubMed ID: 27806619
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric and thermal properties of a newly developed thermobrachytherapy seed with ferromagnetic core for treatment of solid tumors.
Gautam B; Parsai EI; Shvydka D; Feldmeier J; Subramanian M
Med Phys; 2012 Apr; 39(4):1980-90. PubMed ID: 22482619
[TBL] [Abstract][Full Text] [Related]
3. Practical considerations for maximizing heat production in a novel thermobrachytherapy seed prototype.
Gautam B; Warrell G; Shvydka D; Subramanian M; Ishmael Parsai E
Med Phys; 2014 Feb; 41(2):023301. PubMed ID: 24506651
[TBL] [Abstract][Full Text] [Related]
4. Optimization and experimental characterization of the innovative thermo-brachytherapy seed for prostate cancer treatment.
Taghizadeh S; Shvydka D; Shan A; Mian OY; Parsai EI
Med Phys; 2024 Feb; 51(2):839-853. PubMed ID: 38159297
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
[TBL] [Abstract][Full Text] [Related]
7. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
Afsharpour H; D'Amours M; Coté B; Carrier JF; Verhaegen F; Beaulieu L
Med Phys; 2008 Aug; 35(8):3671-81. PubMed ID: 18777927
[TBL] [Abstract][Full Text] [Related]
8. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
10. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers.
Landry G; Reniers B; Lutgens L; Murrer L; Afsharpour H; de Haas-Kock D; Visser P; van Gils F; Verhaegen F
Med Phys; 2012 Mar; 39(3):1410-7. PubMed ID: 22380373
[TBL] [Abstract][Full Text] [Related]
11. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
12. Impact of interseed attenuation and tissue composition for permanent prostate implants.
Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R
Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
14. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
Mobit P; Badragan I
Phys Med Biol; 2004 Jul; 49(14):3171-8. PubMed ID: 15357190
[TBL] [Abstract][Full Text] [Related]
15. Dose uniformity of ferromagnetic seed implants in tissue with discrete vasculature: a numerical study on the impact of seed characteristics and implantation techniques.
van Wieringen N; Kotte AN; van Leeuwen GM; Lagendijk JJ; van Dijk JD; Nieuwenhuys GJ
Phys Med Biol; 1998 Jan; 43(1):121-38. PubMed ID: 9483627
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
17. An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.
Safigholi H; Sardari D; Karimi Jashni S; Mahdavi SR; Meigooni AS
J Appl Clin Med Phys; 2013 May; 14(3):4226. PubMed ID: 23652254
[TBL] [Abstract][Full Text] [Related]
18. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
Chibani O; Williamson JF
Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
[TBL] [Abstract][Full Text] [Related]
19. Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy.
Sutherland JG; Miksys N; Furutani KM; Thomson RM
Med Phys; 2014 Jan; 41(1):011712. PubMed ID: 24387504
[TBL] [Abstract][Full Text] [Related]
20. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
